Carterra Named Top Life Science Tools Provider for AI Drug Discovery

Got story updates? Submit your updates here. ›

In a recent analysis, William Blair analysts named Carterra, a life science tools company based in Salt Lake City, Utah, as a top provider poised to capitalize on the growing use of AI in early drug discovery workflows. The analysts asserted that wet lab experiments will likely increase as AI becomes more prevalent in the drug discovery process, and they highlighted Carterra's HT-SPR technology platforms as key enablers for this trend.

Why it matters

As AI and machine learning continue to transform the drug discovery landscape, the ability to rapidly generate high-quality experimental data to train and validate these AI models will be critical. Carterra's specialized life science tools that can operate at unprecedented scale are seen as a key competitive advantage in supporting the increasing demand for wet lab work driven by the rise of AI-powered drug discovery.

The details

Carterra's HT-SPR (high-throughput surface plasmon resonance) technology platforms allow researchers to analyze thousands of molecular interactions in parallel, providing the large datasets needed to train and validate AI drug discovery models. This capability is seen as crucial as the industry shifts towards more AI-driven workflows in the early stages of the drug development pipeline.

• The William Blair analysis was published on April 8, 2026.